| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 05/08/2008 | US20080108807 Immunosuppressants; autoimmune disease; antiinflammatory agents; multiple sclerosis; rheumatic diseases; antiarthritic agents; aids; for example, 2-{6-[3-Amino-piperidin-1-yl]-3-ethyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl}-benzonitrile |
| 05/08/2008 | US20080108778 Lactic acid-glycolic acid polymer having ratio or weight average molecular weight and number average molecular weight of about 1.90 or lower, or a salt thereof, and a physiologically active substance; for treating prostate cancer, prostatomegaly, endometriosis, hysteromyoma, metrofibroma, breast cancer |
| 05/08/2008 | US20080108688 Used for hypertension, heart failure, stroke, myocardial infarction, diabetes and cardiovascular disease; stabilized to control degradation to the active metabolite ramiprilat instead of ramipril diketopiperazine |
| 05/08/2008 | US20080108596 Antiserotonine agents; psycholgical disorders; headaches; kits |
| 05/08/2008 | US20080108592 treating respiratory diseases, e.g., pediatric asthma, in a continuing regimen with not more than one daily dose of the drug budesonide using a nebulizer |
| 05/08/2008 | US20080108590 Transdermal formulation containing androgen, macrocyclic ester or ketone enhancer and thickenier; extended time high blood serum concentration; rapidly absorbed gel |
| 05/08/2008 | US20080108575 Preparation of formulations of angiotensin II AT1 receptors antagonists for the treatment of arterial hypertension, other cardiovascular illnesses and its complications |
| 05/08/2008 | US20080108570 Treating a skin wrinkle; reduced toxicity and/or a reduced immunogenicity, storage stability; e.g. hydroxyalkyl starch; genetic engineered albumin |
| 05/08/2008 | US20080108554 Method and apparatus for producing dry particles |
| 05/08/2008 | US20080107780 Sugar coatings and methods therefor |
| 05/08/2008 | US20080107758 Mixture with alcohol, propellant and isopropyl myristate; antiinflammatory agents; clobetasol proprionate, fluocinonide, triamcinolone acetonide, fluocinolene acetonide; black cumin, black raspberry, red raspberry, pumpkin seed oil, chardonnay grape seed oil, carrot seed oil; skin disorders |
| 05/08/2008 | US20080107749 Polymeric nanoparticles with hydrophobic core and hydrophilic shell N-isopropyl acrylamide; oral or parenteral; water-soluble vinylpyrolidone, vinyl acetate; or water insoluble methyl methacrylate, styrene, acrylic acid; chemotherapeutics, contrasting agents, antibodies, radionucleides, ligands, medicine |
| 05/08/2008 | US20080107748 Microcapsules for removing and absorbing a chemical from a mixture |
| 05/08/2008 | US20080107747 Pain relief composition |
| 05/08/2008 | US20080107746 Anti-inflamatory inhalation pharmaceutical composition |
| 05/08/2008 | US20080107745 Controlled release sterile injectable aripiprazole formulation and method |
| 05/08/2008 | US20080107744 Natural, synthetic polymer, metal, metal oxide, glass, carbon, ceramic, degradable or non-degradable; smooth, non-tacky and non-porous outer surfaces; polymethylmethacrylate outer shell, gas or liquid filled; radiopaque agent, contrast agent, bioactive ingredient, pharmaceutics; water, alcohol carrier |
| 05/08/2008 | US20080107743 Enhancing ceramide synthesis; topical calcium glycerophosphate and a fatty acid source derived from an animal or a vegetable; inhibits dephosphorylation of spingosine-1-phosphate; enhances conversion of phosphatidyl choline to phosphocholine and of phosphocholine to sphingomyelin and to ceramide |
| 05/08/2008 | US20080107742 Alkalinizing agent, humectant, detergent, wetting agent, antibacterial agent, stabilizer, emulsifier, antifungal agent, colorants, moisturizer, thickening agent, preservative, filler, keratolytic agent; menthol, camphor counterirritants; granules, beads, microspheres, grit, pumice, polymer, sand, glass |
| 05/08/2008 | US20080107741 Angiogenesis inhibitor particles having a particle size of less than 2000 nm; and associated with the surface thereof at least one surface stabilizer |
| 05/08/2008 | US20080107740 Dry powder inhaler; metered dose nebulization; asthma or other inflammatory respiratory disorders; correct molecular ratio of salmeterol active in the lung while budesonide active in the lung can be ensured |
| 05/08/2008 | US20080107739 Kill particular cells in vivo; system communicates via sound, light, magnetic fields, electric fields, RF, vibration; propulsion via legs, cilia, flagella; energy generation system is metabolic; contains sensor; shell of biological material dissolves in body; disguised from immune system; drug delivery |
| 05/08/2008 | US20080107738 Ophthalmic Emulsions Containing Prostaglandins |
| 05/08/2008 | US20080107737 Crosslinked Amine Polymers |
| 05/08/2008 | US20080107736 Nanoparticulate suspension of a corticosteroid compound; a second solvent promotes active compound precipitation; substantially free of surfactant; optically clear; particulate of a desired particle size; prepared without the use of mechanical shearing; increased bioavailability |
| 05/08/2008 | US20080107735 Topical antifungal agent treating onychomycosis; itraconazole, clotrimazole, variconazole, ciclopirox, terbinafine; NSAID anti-inflammatory agent ketoprofen, cyclooxygenase Type 2 inhibitor; Hsieh-type non-irritating permeation enhancer is cyclopentadecalactone or cylcohexadecanone; organogel |
| 05/08/2008 | US20080107734 Healing powder and method of use thereof |
| 05/08/2008 | US20080107733 Formulation Obtained From A Powder Mixture Comprising An Inorganic Pigment |
| 05/08/2008 | US20080107732 Gastric Retention System |
| 05/08/2008 | US20080107731 Dipeptidyl peptidase IV inhibitor; diluents of cellulose powder, dibasic calciumphosphate anhydrous, erythritol; binder of copovidone, hydroxypropyl methylcellulose; disintegrant corn starch; lubricant of talc, polyethyleneglycol, calcium behenate, calcium stearate; glidant is colloidal silicon dioxide |
| 05/08/2008 | US20080107730 Sustained release pharmaceutical preparations and methods for producing the same |
| 05/08/2008 | US20080107729 Orally disintegrating compositions |
| 05/08/2008 | US20080107728 Formula and method for making relief lozenges and method by which ingredients in lozenges are delivered to user |
| 05/08/2008 | US20080107727 Multiple Unit Oral Sustained Release Preparation and Production Method Thereof |
| 05/08/2008 | US20080107726 Compositions comprising beta-adrenergic receptor antagonists and diuretics |
| 05/08/2008 | US20080107725 Physically unstable crystalline form of a therapeutically effective compound; rapid, reproducible, and complete dissolution profiles |
| 05/08/2008 | US20080107724 Method of inhibiting side effects of pharmaceutical compositions containing amphiphilic vehicles or drug carrier molecules |
| 05/08/2008 | US20080107723 Methods of Treating Pulmonary Distress |
| 05/08/2008 | US20080107722 Method For Loading Multiple Agents Into Delivery Vehicles |
| 05/08/2008 | US20080107721 Combination Chemotherapy Comprising A Liposomal Platinum Complex |
| 05/08/2008 | US20080107720 Topical delivery of codrugs |
| 05/08/2008 | US20080107719 Transdermal drug delivery system |
| 05/08/2008 | US20080107714 Use of a vector comprising a nucleic acid encoding an anti-angiogenic factor for the treatment of corneal neovascularization |
| 05/08/2008 | US20080107713 Contact lens as a sustained drug delivery implant |
| 05/08/2008 | US20080107712 Ocular implant made by a double extrusion process |
| 05/08/2008 | US20080107711 Bioabsorbable Implantable Material Fortified with Antibiotics for Localized Delivery of Drugs |
| 05/08/2008 | US20080107710 Matrix material of a membrane sheet from native insoluble collagen I, or collagen III; matrix material carrying a nucleic acid sequence encoding a protein that promotes cell growth |
| 05/08/2008 | US20080107709 Radio-opaque polymeric biomaterials |
| 05/08/2008 | US20080107708 Protoelastin made from human recombinant tropoelastin, splice variants of tropoelastin, chemically modified tropoelastin, recombinant tropoelastin fragments, tropoelastin covalently bound to a metal, ceramic, bone, or polymeric substrate, a tropoelastin-polymer laminate |
| 05/08/2008 | US20080107707 Polymerizable antimicrobial composition |
| 05/08/2008 | US20080107703 Hydrogel For Medical Use |
| 05/08/2008 | US20080107699 Method of using topical probiotics for the inhibition of surface contamination by a pathogenic microorganism and composition therefor |
| 05/08/2008 | US20080107694 Glycolic acid-lactic acid copolymer; biocompatible; biodegradable; RNA interference; inhibitors of vascular endothelial growth factor (VEGF); ocular disorders |
| 05/08/2008 | US20080107631 Liquid mixture comprising cryoprotectants and lyoprotectants for use in long term storage of viral particles |
| 05/08/2008 | US20080107610 Breath freshening and oral cleansing product with magnolia bark extract |
| 05/08/2008 | US20080107609 Administering mometasone furoate and lactose particles from a multidose dry powder inhaler in daily doses of 800 mu g where at least about 250 mu g of the particles have sizes equal to or less than about 6.5 mu m. |
| 05/08/2008 | US20080107608 selective modulators of corticotropin -releasing factor (CRF) receptors, central and periphereal nervous system disorders; antidepressant, anxiolytic agent; stress, cardiovascular disorders, and eating disorders; probes for the localization of CRF receptors |
| 05/08/2008 | US20080105546 Electrohydrodynamic method for processing liquids using electric fields without denaturing biological material or sensitive molecules, and thus benefits from producing comminutes with controlled diameter and charge |
| 05/08/2008 | DE202006020223U1 Pharmazeutische Zusammensetzung Pharmaceutical composition |
| 05/08/2008 | DE112006000921T5 Nanopartikuläre Zusammensetzungen zur kontrollierten Freisetzung, die Prostaglandin-Derivate umfassen Nanoparticulate compositions for controlled release comprising prostaglandin derivatives |
| 05/08/2008 | DE10252726B4 Mehrschichtiges transmucosales therapeutisches System Multilayer transmucosal therapeutic system |
| 05/08/2008 | CA2668273A1 Methods and devices to test diffusion rates of ocular drug delivery systems |
| 05/08/2008 | CA2668267A1 Elvucitabine pharmaceutical compositions |
| 05/08/2008 | CA2668020A1 Liposome encapsulated poly-iclc method to prophylactically treat an avian influenza viral infection |
| 05/08/2008 | CA2667969A1 Method of micronization |
| 05/08/2008 | CA2667953A1 Enzyme inhibition using nanoparticles |
| 05/08/2008 | CA2667864A1 Formulations of phospholipase enzyme inhibitors |
| 05/08/2008 | CA2667468A1 Methods of producing microparticles |
| 05/08/2008 | CA2666534A1 W/o/w emulsion composition |
| 05/08/2008 | CA2664893A1 Controlled release complex composition comprising angiotensin-ii-receptor blockers and hmg-coa reductase inhibitors |
| 05/08/2008 | CA2634783A1 Anti-hyperproliferative therapies targeting hdgf |
| 05/07/2008 | EP1918377A1 Mammalian cytokine receptor subunit proteins, related reagents and methods |
| 05/07/2008 | EP1917982A1 Product for the treatment of inflammation, bruises and/or ulcers in the oral area and the use of such a product |
| 05/07/2008 | EP1917978A1 Premature ovulation preventive agent |
| 05/07/2008 | EP1917976A1 Adjuvant or pharmaceutical preparation for transdermal or transmucosal administration |
| 05/07/2008 | EP1917973A1 Stable formulation comprising a moisture sensitive drug and manufacturing procedure thereof |
| 05/07/2008 | EP1917971A1 Substained release formulations comprising very low molecular weight polymers |
| 05/07/2008 | EP1917964A1 Percutaneously absorbable ophthalmic preparation |
| 05/07/2008 | EP1917962A1 Pharmaceutical composition for modified release insulin sensitiser |
| 05/07/2008 | EP1917961A1 Capsinoid containing composition |
| 05/07/2008 | EP1917958A2 Improved HIV protease inhibitors pharmaceutical formulations |
| 05/07/2008 | EP1917957A2 Biodegradable ocular implant |
| 05/07/2008 | EP1917301A1 Compositions exhibiting improved flowability |
| 05/07/2008 | EP1917072A2 Vitamin formulation |
| 05/07/2008 | EP1917036A2 Intermolecular association complex of a carrier and of an active principle |
| 05/07/2008 | EP1917035A2 Peroxide removal from drug delivery vehicle |
| 05/07/2008 | EP1917005A1 Device, system, and method comprising microencapsulated proton donor for release of nitric oxide from a polymer |
| 05/07/2008 | EP1917004A2 Method for encapsulating therapeutic substances in cells |
| 05/07/2008 | EP1917003A1 Seamless coated spherical filled capsules |
| 05/07/2008 | EP1917002A2 Solid dosage forms of valsartan and amlodipine and method of making the same |
| 05/07/2008 | EP1917001A2 Pharmaceutical composition comprising a dpp-iv inhibitor |
| 05/07/2008 | EP1917000A2 Sustained release pharmaceutical compositions for highly water soluble drugs |
| 05/07/2008 | EP1916999A2 Tablets with improved dissolution profile |
| 05/07/2008 | EP1916998A1 Sterol ester powder |
| 05/07/2008 | EP1916997A2 Stable aqueous protein or antibody pharmaceutical formulations and their preparation |
| 05/07/2008 | EP1916996A2 Production of an oxaliplatin mixture and a container and a container set for said mixture |
| 05/07/2008 | EP1916995A1 Ph-controlled pulsatile delivery system, methods for preparation and use thereof |
| 05/07/2008 | EP1916994A2 Manufacturing of quick release pharmaceutical composition of water insoluble drugs and pharmaceutical compositions obtained by the process of the invention |
| 05/07/2008 | EP1916987A1 Food additive for supplying mineral substances |
| 05/07/2008 | EP1694312B1 Iron salt coated with alginate and method for the preparation thereof |